NGFR and brain injury: Preclinical animal studies of brain injuries have demonstrated how various p75NTR inhibitors, including EVT901 and LM11A-31, induce neuroprotective effects following injury, suggesting that p75NTR may be a viable therapeutic target for future pharmacological investigations [25,28].